SA
MMED logo
MiniMed Group, Inc.(MMED)
Closing price · checked 5:05 PM ETAbout this dataData status
$16.26▼-0.73 (-4.30%)
After Hours:$16.26+0.00 (+0.00%)· 5:05 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 28.4 · elevated volatility

Overview →

MiniMed Group, Inc. (MMED)

R&D to Revenue

14.44%

Fiscal year · Period ending:

MMED logo

MMED R&D to Revenue

Latest reported14.44%
MMED FY R&D/Revenue (19.11% → 14.44%)
High-resolution chart · PNG

What is r&d to revenue?

R&D spending as percentage of revenue.

MMED r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

MiniMed Group, Inc. R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
14.4423%
16.1326%
17.6995%
19.1091%

Frequently asked questions: MMED r&d to revenue

What is MiniMed Group, Inc. (MMED)'s current r&d to revenue?

MiniMed Group, Inc. (MMED)'s latest reported r&d to revenue (Fiscal year) is 14.44% as of Apr 24, 2026. R&D spending as percentage of revenue.

How much historical r&d to revenue data is available for MMED?

Stock Alarm Pro provides 4 dated annual fiscal periods observations for MiniMed Group, Inc. (MMED)'s r&d to revenue, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare MMED's r&d to revenue to peers or set an alert?

You can open MMED's r&d to revenue in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on MMED delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.